Pluxee's stock is trading at €10.54 this Tuesday midday, marking a 2.63% increase from the previous day's close of €10.27. This rebound occurs in a context of a moderate recovery of the CAC 40, which is up 0.73% during the session. However, the momentum remains fragile for the employee benefits specialist, whose share price has dropped nearly 48.5% over the year.
This Tuesday, Pluxee is experiencing a bullish surge after several weeks of decline. Over three months, the stock still shows a decrease of 20.69%, while the performance over seven days remains almost stable (+0.29%). This rebound is part of a generally positive session for the Parisian stock market, with the SBF 120 up 0.77% during the session. The market environment remains tense, as evidenced by the VIX volatility index, which was at 31.05 points at last Friday's close, indicating high stress levels. Geopolitical tensions in the Middle East, with oil prices soaring beyond $115 per barrel on Monday, affect overall visibility, although their direct impact on Pluxee's business—focused on prepaid services and employee benefits—is not immediate. In terms of sector comparison, Capgemini is up 3.55% during the session, while Sartorius Stedim Biotech is down 1.71%.
Technical Analysis and Financial Outlook
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Technically, Pluxee's stock price is below its 50-day moving average (€10.97) and remains far from its 200-day moving average (€14.60), indicating a persistent bearish trend that has not yet reversed. The RSI, a momentum indicator measuring the speed of price changes, stands at 44, which is a neutral level but still oriented below the threshold of 50, suggesting that selling pressure has not completely disappeared. The nearest technical support is at €9.97, a zone tested during recent lows. Regarding the financial calendar, investors are awaiting the publication of the first half of 2026 results, scheduled for April 16. This milestone will be an important point to assess the operational trajectory of the group, which emerged from the split of Sodexo, in a year marked by persistent pressure on stock valuation.
SectorTickets restaurants›Services de traitement des transactions
Context
Period
Period: 1T 2026
Guidance from the release
Trimestre après trimestre, nous enregistrons un démarrage solide de l’exercice 2026, porté par la dynamique commerciale de l'activité Avantages aux salariés; nous avons poursuivi notre feuille de route stratégique avec les acquisitions de Skipr et ProEves et restons confiants dans notre capacité à délivrer des performances durables malgré un environnement réglementaire exigeant au Brésil.
Démarrage robuste au T1 2026 : chiffre d'affaires total de 308 M€ (+9,0 % organique), solide croissance en Amérique latine, effet de change négatif (notamment livre turque) et impact réglementaire potentiel au Brésil; exécution active de la stratégie M&A.
Risks mentioned
Évolutions réglementaires au Brésil pouvant impacter les résultats (impact anticipé H1 2027 si confirmées)
Effets de change défavorables (dépréciation de la livre turque, impact sur croissance publiée)
Fin ou redimensionnement des programmes d'aide publique en Europe continentale
Report de commande d'un large programme en Roumanie affectant le timing du volume d'affaires
Opportunities identified
Pipeline M&A solide et diversifié permettant d'accroître l'offre multi-avantages
Croissance soutenue en Amérique latine, en particulier au Brésil
Renforcement de l'offre via les acquisitions de Skipr (mobilité) et ProEves (garde d'enfants) pour pénétrer de nouveaux segments
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
